We Think That There Are More Issues For Amgen (NASDAQ:AMGN) Than Just Sluggish Earnings

Simply Wall St20:53

Amgen, AstraZeneca Post Phase 3 Win for Nasal Polyps Therapy

Seeking Alpha19:38

Amgen's Chronic Rhinosinusitis Drug Meets Main, Secondary Goals in Phase 3 Trial

MT Newswires17:54

Express News | Tezspire Met Both Co-Primary Endpoints in Phase 3 Trial for Chronic Rhinosinusitis With Nasal Polyps

Breakings15:00

Coherus Stock Rallies 19% on Q3 Earnings, Udenyca Production Update

Seeking Alpha04:56

SA Asks: How Will the U.S. Election Results Impact Healthcare Stocks?

Seeking AlphaNov 7 04:17